BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3622395)

  • 1. Treatment of pituitary dwarfism with authentic recombinant human growth hormone (SM-9500).
    Takano K; Shizume K; Hibi I; Okuno A; Hanyu K; Suwa S; Nakajima H; Kondo T; Kato K; Iwatani N
    Endocrinol Jpn; 1987 Apr; 34(2):291-7. PubMed ID: 3622395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of idiopathic pituitary dwarfism with methionyl human growth hormone.
    Takano K; Shizume K; Hizuka N; Hibi I; Kato K; Kohno H; Kondo T; Ogawa M; Okada Y; Sudo M
    Endocrinol Jpn; 1983 Aug; 30(4):523-7. PubMed ID: 6671456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case report of growth attenuation during methionyl human growth hormone treatment.
    Okada Y; Taira K; Takano K; Hizuka N
    Endocrinol Jpn; 1987 Aug; 34(4):621-6. PubMed ID: 3678156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of second somatonorm treatment in idiopathic growth hormone deficiency dwarfism].
    Bao X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Dec; 13(6):443-6. PubMed ID: 1838961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of pituitary dwarfism with methionyl human growth hormone in Japan.
    Takano K; Shizume K; Hizuka N; Okuno A; Umino T; Kobayashi Y; Kusano S; Nakajima H; Irie M; Hibi I
    Endocrinol Jpn; 1986 Oct; 33(5):589-96. PubMed ID: 3830068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trial with authentic recombinant somatropin in Japan.
    Takano K; Shizume K; Hibi I; Okuno A; Nakajima H; Suwa S; Nogawa T; Kondo T; Momoi T; Iwatani N
    Acta Paediatr Scand Suppl; 1987; 331():18-24. PubMed ID: 3300151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with somatrem in Japan.
    Takano K; Shizume K
    Acta Paediatr Scand Suppl; 1986; 325():19-24. PubMed ID: 3296635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current clinical trials with authentic recombinant human growth hormone in Japan.
    Takano K; Shizume K
    Acta Paediatr Scand Suppl; 1986; 325():93-7. PubMed ID: 3296643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical studies with recombinant-DNA-derived methionyl human growth hormone in growth hormone deficient children.
    Kaplan SL; Underwood LE; August GP; Bell JJ; Blethen SL; Blizzard RM; Brown DR; Foley TP; Hintz RL; Hopwood NJ
    Lancet; 1986 Mar; 1(8483):697-700. PubMed ID: 2870221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Turner's syndrome with methionyl human growth hormone for six months.
    Takano K; Hizuka N; Shizume K
    Acta Endocrinol (Copenh); 1986 May; 112(1):130-7. PubMed ID: 3521183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Authentic recombinant human growth hormone. Results of a multicenter clinical trial in patients with growth hormone deficiency.
    Rasmussen LH; Zachmann M; Nilsson P
    Helv Paediatr Acta; 1989 Jun; 43(5-6):443-8. PubMed ID: 2663792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant DNA produced somatropin in the treatment of prepubertal growth hormone deficient children.
    Chang TC; Kuo HF; Liu PC; Shih KC; Zeisel HJ; Ho LT
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Jan; 47(1):7-12. PubMed ID: 1848467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of somatomedin A and growth during long-term treatment of patients with pituitary dwarfism with human growth hormone.
    Takano K; Hizuka N; Shizume K; Hasumi Y
    Acta Endocrinol (Copenh); 1979 Nov; 92(3):385-97. PubMed ID: 229685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current clinical trials with authentic recombinant somatropin in Japan.
    Hibi I; Takano K; Shizume K
    Acta Paediatr Scand Suppl; 1987; 337():141-6. PubMed ID: 3324635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicentre clinical trial of authentic recombinant somatropin in growth hormone deficiency.
    Bierich JR
    Acta Paediatr Scand Suppl; 1987; 337():135-40. PubMed ID: 3324634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of 94 patients with Turner's syndrome with recombinant human growth hormone (SM-9500) for two years--the results of a multicentric study in Japan. Committee for the Treatment of Turner's Syndrome.
    Takano K; Shizume K; Hibi I
    Endocrinol Jpn; 1989 Aug; 36(4):569-78. PubMed ID: 2684622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hypopituitarism with recombinant somatropin for 1 year.
    Takano K; Shizume K; Hibi I; Okuno A; Hanyu K; Suwa S; Nakajima H; Kondo T; Kato K; Iwatani N
    Acta Paediatr Scand Suppl; 1988; 347():169-75. PubMed ID: 3254031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methionyl human growth hormone and oxandrolone in Turner syndrome: preliminary results of a prospective randomized trial.
    Rosenfeld RG; Hintz RL; Johanson AJ; Brasel JA; Burstein S; Chernausek SD; Clabots T; Frane J; Gotlin RW; Kuntze J
    J Pediatr; 1986 Dec; 109(6):936-43. PubMed ID: 3537249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of pituitary dwarfism with biosynthetic growth hormone.
    Bierich JR
    Acta Paediatr Scand Suppl; 1986; 325():13-8. PubMed ID: 3296634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterologous humoral immune response in patients treated with human growth hormone from different sources.
    Cardoso AI; Llera AS; Iacono RF; Domené HM; Martínez AS; Heinrich JJ; Peña C; Poskus E
    Acta Endocrinol (Copenh); 1993 Jul; 129(1):20-5. PubMed ID: 8351954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.